Legend Biotech Corp ADR (LEGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 459,277 | 201,253 | 897,571 | 1,277,713 | 963,470 |
| Marketable Securities | 753,706 | 1,091,017 | 405,165 | 31,361 | 460,723 |
| Receivables | 705 | 13,064 | 3,307 | 100,041 | 20 |
| Inventories | 23,548 | 18,870 | 22,146 | 19,433 | 18,014 |
| TOTAL | $1,350,037 | $1,424,832 | $1,413,792 | $1,497,799 | $1,508,796 |
| Non-Current Assets | |||||
| PPE Net | 104,031 | 105,018 | 105,278 | 108,725 | 109,503 |
| Investments And Advances | 376 | 295 | 563 | 451 | 419 |
| Intangibles | 2,507 | 2,772 | 3,152 | 4,061 | 4,009 |
| Other Non-Current Assets | 278,874 | 265,266 | 252,322 | 237,573 | 216,607 |
| TOTAL | $385,788 | $373,351 | $361,315 | $350,810 | $330,538 |
| Total Assets | $1,735,825 | $1,798,183 | $1,775,107 | $1,848,609 | $1,839,334 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 191,770 | 209,021 | 175,497 | 132,802 | 161,824 |
| Other current liabilities | 63,715 | 75,390 | 63,789 | 53,078 | 630 |
| TOTAL | $270,894 | $294,302 | $249,675 | $216,418 | $175,222 |
| Non-Current Liabilities | |||||
| Long Term Debt | 296,623 | 291,559 | 286,396 | 281,328 | 275,906 |
| Other Non-Current Liabilities | 52,201 | 53,320 | 74,977 | 99,492 | 48,570 |
| TOTAL | $348,824 | $344,879 | $361,373 | $380,820 | $324,476 |
| Total Liabilities | $619,718 | $639,181 | $611,048 | $597,238 | $499,698 |
| Shareholders' Equity | |||||
| Common Shares | 37 | 37 | 36 | 36 | 36 |
| Retained earnings | 1,116,070 | 1,158,965 | 1,164,023 | 1,251,335 | 1,339,600 |
| TOTAL | $1,116,107 | $1,159,002 | $1,164,059 | $1,251,371 | $1,339,636 |
| Total Liabilities And Equity | $1,735,825 | $1,798,183 | $1,775,107 | $1,848,609 | $1,839,334 |